This was a multicenter, retrospective cohort study in adult patients with advanced nonhematologic malignancies who underwent a CGP test. If patients received a targeted therapy for ≥ 6 months, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback